Caffeine citrate

Caffeine citrate</span>"}]]}'>Caffeine citrate

Clinical data
Trade names	Cafcit, Gencebok, Cafnea, others
AHFS/Drugs.com	Monograph
License data	United States</span>"}]]}'>US DailyMed: Caffeine_citrate
Routes of administration	By mouth, intravenous (IV)
ATC code	AU:Unscheduled Canada</span>"}]]}'>CA: ℞-only United States</span>"}]]}'>US:℞-only European Union</span>"}]]}'>EU:Rx-only
Identifiers
IUPAC name 1,3,7-trimethylpurine-2,6-dione; 2-hydroxypropane-1,2,3-tricarboxylic acid
CAS Number	6241
ChemSpider	D07603
ChEMBL	DTXSID5046938 Interactive image
SMILES CN1C=NC2=C1C(=O)N(C(=O)N2C)C.C(C(=O)O)C(CC(=O)O)(C(=O)O)O
InChI InChI=1S/C8H10N4O2.C6H8O7/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2;7-3(8)1-6(13,5(11)12)2-4(9)10/h4H,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12) Key:RCQXSQPPHJPGOF-UHFFFAOYSA-N
(verify)

Caffeine citrate, sold under the brand name Cafcit among others, is a medication used to treat a lack of breathing in premature babies. Specifically it is given to babies who are born at less than 35 weeks or weigh less than